Clinical Trial Update: Delayed Renal Allograft Function and Furosemide Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating furosemide for delayed graft function after renal transplantation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Graft Function

Drugs mentioned

• FUROSEMIDE (Furosemide)

Snippet

Sponsor: Loma Linda University | Conditions: Delayed Graft Function | Phase 2 | Status: WITHDRAWN